Open AccessSuccessful treatment of cerebral toxoplasmosis with cotrimoxazole
Author(s) -
Harsha V. Patil,
Virendra C. Patil,
Vijaya S. Rajmane,
Vinayak Raje
Publication year - 2011
Publication title -
indian journal of sexually transmitted diseases
Language(s) - English
Resource type - Journals
eISSN - 1998-3816
pISSN - 0253-7184
DOI - 10.4103/0253-7184.81255
Subject(s) - medicine , toxoplasmosis , pediatrics , levetiracetam , incidence (geometry) , epilepsy , aids related opportunistic infections , human immunodeficiency virus (hiv) , lesion , immunology , surgery , sida , viral disease , psychiatry , physics , optics
Cerebral toxoplasmosis is an acquired immunodeficiency syndrome (AIDS)-related infection and is one of the causes of CNS mass lesions in AIDS. Toxoplasmosis is the most common cerebral mass lesion encountered in HIV-infected patients, and its incidence has increased markedly since the beginning of the AIDS epidemic. Cerebral toxoplasmosis is associated with high mortality and morbidity in patients with acquired immunocopromised state. We are reporting a case of cerebral toxoplasmosis presented with status epileptics and treated with cotrimoxazole. Refractory status epilepsy was controlled with intravenous levetiracetam, which has a unique drug profile.